Company page

Skye Bioscience, Inc.

Skye Bioscience, Inc. is a public company traded under the ticker SKYE in the American market. The company has a market capitalization of approximately $22.9 million. Skye Bioscience focuses on developing innovative therapies, leveraging advancements in biotechnology.